Weibo Luo

9.6k total citations · 4 hit papers
85 papers, 7.4k citations indexed

About

Weibo Luo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Weibo Luo has authored 85 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 42 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Weibo Luo's work include Cancer, Hypoxia, and Metabolism (35 papers), Mitochondrial Function and Pathology (12 papers) and RNA modifications and cancer (10 papers). Weibo Luo is often cited by papers focused on Cancer, Hypoxia, and Metabolism (35 papers), Mitochondrial Function and Pathology (12 papers) and RNA modifications and cancer (10 papers). Weibo Luo collaborates with scholars based in United States, China and Germany. Weibo Luo's co-authors include Gregg L. Semenza, Yingfei Wang, Hongxia Hu, Akhilesh Pandey, Jun Zhong, Georg Reiser, Robert N. Cole, Robert N. O’Meally, Daniele M. Gilkes and Matthew Knabel and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Weibo Luo

83 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1

2011 1.3k citations Weibo Luo, Larissa A. Shimoda et al. profile →
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1

2011 1.2k citations Weibo Luo, Hongxia Hu et al. profile →
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis

2014 412 citations Ting Wang, Daniele M. Gilkes et al. Proceedings of the National Academy of Sciences profile →
Emerging roles of PKM2 in cell metabolism and cancer progression

2012 290 citations Weibo Luo, Gregg L. Semenza profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weibo Luo United States	37	4.2k	3.3k	1.5k	1.1k	568	85	7.4k
Giovanni Melillo United States	44	4.1k 1.0×	3.3k 1.0×	1.5k 1.0×	2.1k 1.8×	689 1.2×	102	7.9k
Bart Ghesquière Belgium	41	3.9k 0.9×	1.7k 0.5×	1.5k 1.0×	719 0.6×	651 1.1×	106	6.6k
David R. Plas United States	35	5.6k 1.3×	3.0k 0.9×	2.6k 1.7×	1.7k 1.5×	719 1.3×	64	8.9k
Yun‐Sil Lee South Korea	44	5.6k 1.3×	2.8k 0.8×	924 0.6×	989 0.9×	673 1.2×	174	8.4k
Chao Lü United States	40	5.5k 1.3×	3.0k 0.9×	720 0.5×	1.0k 0.9×	399 0.7×	112	8.4k
Shigeki Miyamoto United States	42	5.1k 1.2×	3.9k 1.2×	3.0k 1.9×	2.1k 1.9×	453 0.8×	157	8.8k
Juan Miguel Redondo Spain	51	3.8k 0.9×	1.1k 0.3×	1.4k 0.9×	875 0.8×	617 1.1×	135	6.7k
Qiang Yu Singapore	55	6.0k 1.4×	1.9k 0.6×	776 0.5×	1.9k 1.6×	302 0.5×	139	8.4k
Hirotoshi Tanaka Japan	46	4.2k 1.0×	1.9k 0.6×	1.0k 0.7×	1.2k 1.0×	1.0k 1.8×	175	8.0k
David H. Hawke United States	48	7.4k 1.8×	2.7k 0.8×	878 0.6×	1.7k 1.5×	432 0.8×	134	9.9k

Countries citing papers authored by Weibo Luo

Since Specialization

Citations

This map shows the geographic impact of Weibo Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibo Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibo Luo more than expected).

Fields of papers citing papers by Weibo Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weibo Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibo Luo. The network helps show where Weibo Luo may publish in the future.

Co-authorship network of co-authors of Weibo Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Weibo Luo. A scholar is included among the top collaborators of Weibo Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weibo Luo. Weibo Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yong, Lei Bao, Gonçalo Vale, et al.. (2025). ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27. Nature Communications. 16(1). 3908–3908. 3 indexed citations

Zhou, Mi, Shuiqiao Liu, Bo Zhang, et al.. (2025). AIF3 splicing variant elicits mitochondrial malfunction via the concurrent dysregulation of electron transport chain and glutathione-redox homeostasis. Nature Communications. 16(1). 1804–1804. 4 indexed citations

Robinson, Keith S., et al.. (2024). TMBIM6/BI-1 is an intracellular environmental regulator that induces paraptosis in cancer via ROS and Calcium-activated ERAD II pathways. Oncogene. 44(8). 494–512. 2 indexed citations

Zhang, Bo, Hui Peng, Mi Zhou, et al.. (2022). Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in Glioblastoma. Cancer Research. 82(13). 2388–2402. 36 indexed citations

Yang, Mingming, Chenliang Wang, Mi Zhou, et al.. (2022). KDM6B promotes PARthanatos via suppression of O6-methylguanine DNA methyltransferase repair and sustained checkpoint response. Nucleic Acids Research. 50(11). 6313–6331. 11 indexed citations

Liu, Shuiqiao, Weibo Luo, & Yingfei Wang. (2021). Emerging role of PARP‐1 and PARthanatos in ischemic stroke. Journal of Neurochemistry. 160(1). 74–87. 66 indexed citations

Wang, Yijie, Yan Chen, Chenliang Wang, et al.. (2021). MIF is a 3’ flap nuclease that facilitates DNA replication and promotes tumor growth. Nature Communications. 12(1). 2954–2954. 31 indexed citations

Ruan, Zhi, Jennifer E. Wang, Mi Zhou, et al.. (2021). MIF promotes neurodegeneration and cell death via its nuclease activity following traumatic brain injury. Cellular and Molecular Life Sciences. 79(1). 39–39. 14 indexed citations

Wang, Yong, Yan Chen, Yijie Wang, et al.. (2020). ZMYND8 Expression in Breast Cancer Cells Blocks T-Lymphocyte Surveillance to Promote Tumor Growth. Cancer Research. 81(1). 174–186. 15 indexed citations

10.

Wang, Yijie, Yan Chen, Lei Bao, et al.. (2020). CHD4 Promotes Breast Cancer Progression as a Coactivator of Hypoxia-Inducible Factors. Cancer Research. 80(18). 3880–3891. 45 indexed citations

11.

Peng, Hui, Yingfei Wang, & Weibo Luo. (2020). Multifaceted role of branched-chain amino acid metabolism in cancer. Oncogene. 39(44). 6747–6756. 147 indexed citations

12.

Chen, Yan, Bo Zhang, Lei Bao, et al.. (2018). ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis. Journal of Clinical Investigation. 128(5). 1937–1955. 128 indexed citations

13.

Luo, Weibo, Ivan Chen, Yan Chen, et al.. (2016). PRDX2 and PRDX4 are negative regulators of hypoxia-inducible factors under conditions of prolonged hypoxia. Oncotarget. 7(6). 6379–6397. 31 indexed citations

14.

Wang, Ting, Daniele M. Gilkes, Naoharu Takano, et al.. (2014). Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis. Proceedings of the National Academy of Sciences. 111(31). E3234–42. 412 indexed citations breakdown →

15.

Hu, Hongxia, Naoharu Takano, Lisha Xiang, et al.. (2014). Hypoxia-inducible factors enhance glutamate signaling in cancer cells. Oncotarget. 5(19). 8853–8868. 58 indexed citations

16.

Chapiro, Julius, Surojit Sur, Lynn Jeanette Savic, et al.. (2014). Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer. Clinical Cancer Research. 20(24). 6406–6417. 48 indexed citations

17.

Takano, Naoharu, Yingjie Peng, Ganesh Kumar, et al.. (2013). Hypoxia-inducible factors regulate human and rat cystathionine β-synthase gene expression. Biochemical Journal. 458(2). 203–211. 36 indexed citations

18.

Chaturvedi, Pallavi, Daniele M. Gilkes, Carmen Chak‐Lui Wong, et al.. (2012). Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis. Journal of Clinical Investigation. 123(1). 189–205. 214 indexed citations

19.

Hubbi, Maimon E., Weibo Luo, Jin Hyen Baek, & Gregg L. Semenza. (2011). MCM Proteins Are Negative Regulators of Hypoxia-Inducible Factor 1. Molecular Cell. 42(5). 700–712. 73 indexed citations

20.

Luo, Weibo, Yingfei Wang, & Georg Reiser. (2005). Two types of protease-activated receptors (PAR-1 and PAR-2) mediate calcium signaling in rat retinal ganglion cells RGC-5. Brain Research. 1047(2). 159–167. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact